Integrated Single Microbead-Arrayed μ-Fluidic Platform for the Automated Detection of Multiplexed Biomarkers

Area of Science:

• Biomedical Engineering
• Analytical Chemistry
• Clinical Diagnostics

Background:

• Multiplex biomarker detection is crucial for disease screening and prognosis.
• Existing immunoassay methods often lack high sensitivity, automation, or multiplexing capabilities.

Purpose of the Study:

• To develop an automated, single microbead-arrayed microfluidic immunoassay (AMIA) device.
• To achieve highly sensitive and simultaneous detection of multiplex biomarkers with full automation.

Main Methods:

• Integration of single microbead manipulation, sample loading, multistep washing, and immunoreaction on a microfluidic chip.
• Utilizing a routine sandwich immunoassay for efficient signal enrichment on single microbeads.

Main Results:

• Simultaneous determination of multiplexed protein biomarkers at pg/mL levels in a small serum volume (∼20 μL).
• High sensitivity and multiplexing capability demonstrated.
• Excellent consistency between AMIA results and standard clinical tests for clinically important biomarkers.

Conclusions:

• The AMIA device provides a practical and user-friendly platform for biomarker assaying.
• Its high sensitivity, multiplexing capability, generality, and automation meet clinical demands for diagnostics and point-of-care testing.